Priyanka Gandhi Critiques Modi Government on IMPCL Privatisation Plans
Priyanka Gandhi Questions Modi Government's Intentions
Congress leader Priyanka Gandhi has strongly criticized the Modi government over the proposed privatisation of the Indian Medicines Pharmaceutical Corporation Limited (IMPCL). She raised concerns that the motive behind divesting this Mini Ratna pharmaceutical company seems to be financially benefitting a select group of individuals rather than serving the public interest.
Impact on Local Communities and Ayurveda
Located in Mohaan, Almora, Uttarakhand, the IMPCL was established in 1978 and has made significant contributions by manufacturing Ayurveda and Unani medicines. Priyanka Gandhi highlighted that last year, 'the profit-making enterprise earned 18 crore and is set to provide a 6 crore dividend to the government.' Such profitable ventures are critical to the livelihoods of over 500 employees and thousands of local farmers who supply raw materials.
Hypocrisy in Promoting Ayurveda
Priyanka contended that by attempting to sell a profit-generating factory like IMPCL, the government is demonstrating a hypocrisy in promoting Ayurveda and AYUSH, questioning their commitment to preserving these vital industries.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.